Gain insight into research trends and influential papers with Research Intelligence.
doi.org/10.1161/circulationaha.119.044359

Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7%

..., Kenneth W. Mahaffey
105
Circulation37.80
Volume: 141, Issue: 5, Pages: 407 - 410
Published: Feb 4, 2020
Abstract
HomeCirculationVol. 141, No. 5Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7% Free AccessLetterPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree...
Paper Fields
Paper Details
Title
Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c &lt;7%
DOI
doi.org/10.1161/circulationaha.119.044359
Published Date
Feb 4, 2020
Journal
Circulation
Volume
141
Issue
5
Pages
407 - 410
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.